(0.08%) 5 103.89 points
(0.25%) 38 335 points
(0.09%) 15 942 points
(-1.26%) $82.79
(6.24%) $2.04
(0.01%) $2 347.40
(-0.30%) $27.45
(3.76%) $956.75
(-0.18%) $0.933
(-0.29%) $10.99
(-0.51%) $0.796
(1.69%) $93.43
-0.18% ¥ 1 122.00
Live Chart Being Loaded With Signals
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products...
Stats | |
---|---|
Tagesvolumen | 160 100 |
Durchschnittsvolumen | 486 719 |
Marktkapitalisierung | 141.41B |
EPS | ¥0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( ¥18.80 ) 2024-05-09 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -7.91 |
ATR14 | ¥0.645 (0.06%) |
Volumen Korrelation
PHC Holdings Corporation Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
PHC Holdings Corporation Korrelation - Währung/Rohstoff
PHC Holdings Corporation Finanzdaten
Annual | 2022 |
Umsatz: | ¥356.43B |
Bruttogewinn: | ¥169.13B (47.45 %) |
EPS: | ¥-25.83 |
FY | 2022 |
Umsatz: | ¥356.43B |
Bruttogewinn: | ¥169.13B (47.45 %) |
EPS: | ¥-25.83 |
FY | 2022 |
Umsatz: | ¥340.45B |
Bruttogewinn: | ¥165.24B (48.53 %) |
EPS: | ¥-69.44 |
FY | 2021 |
Umsatz: | ¥306.07B |
Bruttogewinn: | ¥143.65B (46.93 %) |
EPS: | ¥142.35 |
Financial Reports:
No articles found.
PHC Holdings Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥36.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥38.00 | 2022-03-30 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | ¥110.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.96 | -- |
Div. Sustainability Score | 4.10 | |
Div.Growth Potential Score | 2.05 | |
Div. Directional Score | 3.07 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6866.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6238.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4963.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4118.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3349.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
2427.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9364.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8056.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7309.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6555.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0511 | 1.500 | -1.022 | -1.533 | [0 - 0.5] |
returnOnAssetsTTM | -0.0329 | 1.200 | -1.095 | -1.315 | [0 - 0.3] |
returnOnEquityTTM | -0.128 | 1.500 | -2.54 | -3.81 | [0.1 - 1] |
payoutRatioTTM | -0.510 | -1.000 | -5.10 | 5.10 | [0 - 1] |
currentRatioTTM | 1.306 | 0.800 | 8.47 | 6.78 | [1 - 3] |
quickRatioTTM | 0.822 | 0.800 | 9.87 | 7.90 | [0.8 - 2.5] |
cashRatioTTM | 0.325 | 1.500 | 9.31 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.530 | -1.500 | 1.171 | -1.756 | [0 - 0.6] |
interestCoverageTTM | -0.429 | 1.000 | -1.270 | -1.270 | [3 - 30] |
operatingCashFlowPerShareTTM | 341.98 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 224.85 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.30 | -1.500 | 0.805 | -1.207 | [0 - 2.5] |
grossProfitMarginTTM | 0.454 | 1.000 | 5.76 | 5.76 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0188 | 1.000 | -2.38 | -2.38 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.150 | 1.000 | -0.276 | -0.276 | [0.2 - 2] |
assetTurnoverTTM | 0.643 | 0.800 | 9.04 | 7.24 | [0.5 - 2] |
Total Score | 4.10 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7.95 | 1.000 | -0.904 | 0 | [1 - 100] |
returnOnEquityTTM | -0.128 | 2.50 | -1.631 | -3.81 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 224.85 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 6.42 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 341.98 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | -0.510 | 1.500 | -5.10 | 5.10 | [0 - 1] |
pegRatioTTM | -0.125 | 1.500 | -4.17 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.124 | 1.000 | 9.41 | 0 | [0.1 - 0.5] |
Total Score | 2.05 |
PHC Holdings Corporation
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.